Patents by Inventor Jean-Francois Lavallée

Jean-Francois Lavallée has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Diterpenoid compounds, compositions thereof and their use as anti-cancer or anti-fungal agents
    Publication number: 20050070540
    Abstract: The present invention relates to Diterpenoid Compounds, compositions comprising an effective amount of a Diterpenoid Compound, and methods useful for treating or preventing cancer or a neoplastic disorder comprising administering an effective amount of a Diterpenoid Compound. The compounds, compositions, and methods of the invention are also useful for inhibiting the growth of a cancer cell or neoplastic cell, or for inducing apoptosis in a cancer or neoplastic cell. The compounds, compositions, and methods of the invention are further useful for treating or preventing a fungal infection. The compounds, compositions, and methods of the invention are also useful for inhibiting the growth of a fungus.
    Type: Application
    Filed: December 1, 2003
    Publication date: March 31, 2005
    Inventors: Pierre Beauparlant, Giorgio Attardo, Zhiying Zhang, Angela Stafford, Rosa Ubillas, James McAlpine, Jean-Francois Lavallee, Samuel Fortin, Sasmita Tripathy
  • Diterpenoid compounds, compositions thereof and their use as anti-cancer or anti-fungal agents
    Publication number: 20050032802
    Abstract: The present invention relates to Diterpenoid Compounds, compositions comprising an effective amount of a Diterpenoid Compound, and methods useful for treating or preventing cancer or a neoplastic disorder comprising administering an effective amount of a Diterpenoid Compound. The compounds, compositions, and methods of the invention are also useful for inhibiting the growth of a cancer cell or neoplastic cell, or for inducing apoptosis in a cancer or neoplastic cell. The compounds, compositions, and methods of the invention are further useful for treating or preventing a fungal infection. The compounds, compositions, and methods of the invention are also useful for inhibiting the growth of a fungus.
    Type: Application
    Filed: June 10, 2004
    Publication date: February 10, 2005
    Inventors: Jean-Francois Lavallee, Terrence Doyle, Elise Rioux, Laurent Belec, Daniel Rabouin, Xavier Billot
  • Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseases
    Publication number: 20050014802
    Abstract: The present invention relates to novel Triheterocyclic Compounds, compositions comprising a Triheterocyclic Compound, and methods useful for treating or preventing cancer or a neoplastic disorder comprising administering a Triheterocyclic Compound. The compounds, compositions, and methods of the invention are also useful for inhibiting the growth of a cancer cell or neoplastic cell, treating or preventing a viral infection, or inhibiting the replication and/or infectivity of a virus.
    Type: Application
    Filed: May 28, 2004
    Publication date: January 20, 2005
    Inventors: Giorgio Attardo, Kenza Dairi, Jean-Francois Lavallee, Elise Rioux, Sasmita Tripathy, Terrence Doyle, Xavier Billot
  • Compounds useful in pain management
    Patent number: 6844368
    Abstract: The present invention relates to novel oxo-aminotetralin compounds of the formula (I) wherein X, R1, R2, R3, R4, R5, and R6 are defined herein. The compounds of formula (I) are useful in pain management.
    Type: Grant
    Filed: December 14, 1999
    Date of Patent: January 18, 2005
    Inventors: Edward Roberts, Tiechao Li, Dilip Dixit, Krzysztof Bednarski, Jean-Francois Lavallée, Dick Storer, Wuyi Wang
  • Method for the treatment or prevention of Flavivirus infections using nucleoside analogues
    Publication number: 20040248844
    Abstract: The present invention relates to a method for the treatment or prevention of Flavivirus infections using nucleoside analogues in a host comprising administering a therapeutically effective amount of a compound having the formula I or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: July 9, 2004
    Publication date: December 9, 2004
    Inventors: Hicham Moulay Alaoui Ismaili, Yun-Xing Cheng, Jean-Francois Lavallee, Arshad Siddiqui, Richard Storer
  • Method for the treatment or prevention of flavivirus infections using nucleoside analogues
    Patent number: 6784161
    Abstract: The present invention relates to a method for the treatment or prevention of Flavivirus infections using nucleoside analogues in a host comprising administering a therapeutically effective amount of a compound having the formula I or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: February 20, 2001
    Date of Patent: August 31, 2004
    Assignee: BioChem Pharma, Inc.
    Inventors: Hicham Moulay Alaoui Ismaili, Yun-Xing Cheng, Jean-François Lavallée, Arshad Siddiqui, Richard Storer
  • Aromatic derivatives as HIV aspartyl protease inhibitors
    Patent number: 6632816
    Abstract: The present invention provides HIV aspartyl protease inhibitors of the formula; and when the compound of formula I comprises an amino group, pharmaceutically acceptable ammonium salts thereof, wherein n is 3 or 4, wherein R1 may be, for example, iso-butyl, wherein X and Y, same or different, may be, for example, NH2 and F, and wherein R2 and R3 are as defined herein.
    Type: Grant
    Filed: December 23, 2002
    Date of Patent: October 14, 2003
    Assignee: Pharmacor Inc.
    Inventors: Brent Richard Stranix, Jean-François Lavallée, Nicolas LeBerre, Valérie Perron
  • Antiviral compounds
    Patent number: 6534520
    Abstract: The present invention relates to heterocyclic Compounds having antiviral activity. In particular, Compounds of formula (I): wherein B, W, X, Y, Q, R1, R2, R3, R4 and n are as defined herein, are useful in the therapy and prophylaxis of viral infection in mammals.
    Type: Grant
    Filed: February 5, 2001
    Date of Patent: March 18, 2003
    Assignee: BioChem Pharma Inc.
    Inventors: Jean Bédard, Robert Rando, Jean-Francois Lavallée, Guy Falardeau
  • Dioxolane analogs for improved inter-cellular delivery
    Publication number: 20030013660
    Abstract: Dioxolane analogs of the following formula: 1
    Type: Application
    Filed: October 15, 2001
    Publication date: January 16, 2003
    Applicant: Shire BioChem Inc.
    Inventors: Giorgio Attardo, Boulos Zacharie, Rabindra Rej, Jean-Francois Lavallee, Louis Vaillancourt, Real Denis, Sophie Levesque
  • Method for the treatment or prevention of flavivirus infections using nucleoside analogues
    Publication number: 20020019363
    Abstract: The present invention relates to a method for the treatment or prevention of Flavivirus infections using nucleoside analogues in a host comprising administering a therapeutically effective amount of a compound having the formula I or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: February 20, 2001
    Publication date: February 14, 2002
    Inventors: Hicham Moulay Alaoui Ismaili, Yun-Xing Cheng, Jean-Francois Lavallee, Arshad Siddiqui, Richard Storer
  • Antiviral compounds
    Publication number: 20010031765
    Abstract: The present invention relates to heterocyclic Compounds having antiviral activity.
    Type: Application
    Filed: February 5, 2001
    Publication date: October 18, 2001
    Applicant: BioChem Pharma Inc.
    Inventors: Jean Bedard, Robert Rando, Jean-Francois Lavallee, Guy Falardeau
  • Antiviral compounds
    Patent number: 6255318
    Abstract: The present invention relates to heterocyclic Compounds having antiviral activity. In particular, Compounds of formula (I): wherein B, W, X, Y, Q, R1, R2, R3, R4 and n are as defined herein, are useful in the therapy and prophylaxis of viral infection in mammals.
    Type: Grant
    Filed: December 11, 1998
    Date of Patent: July 3, 2001
    Assignee: Biochem Pharma Inc.
    Inventors: Jean Bédard, Robert Rando, Jean-Francois Lavallée, Guy Falardeau
  • Cytomegalovirus inhibiting compounds
    Patent number: 5945431
    Abstract: The present invention relates to heterocyclic compounds having antiviral activity. In particular, compounds of formula (I): wherein B, W, X, Y, R.sub.1, R.sub.2, R.sub.3, R.sub.4 and n are as defined herein, are useful in the therapy and prophylaxis of cytomegalovirus (CMV) infection in mammals.
    Type: Grant
    Filed: September 4, 1997
    Date of Patent: August 31, 1999
    Assignee: Biochem Therapeutics Incorporated
    Inventors: Haolun Jin, Laval C. Chan, Wei Wang, Tomislav Stefanac, Tarek S. Mansour, Paul Nguyen-Ba, Jean-Francois Lavallee, Guy Falardeau